Fangfang Liu Selected Research

purpurogallin

1/2019

Purpurogallin is a novel mitogen-activated protein kinase kinase 1/2 inhibitor that suppresses esophageal squamous cell carcinoma growth in vitro and in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Fangfang Liu Research Topics

Disease

65	Neoplasms (Cancer) 07/2022 - 01/2010
20	Breast Neoplasms (Breast Cancer) 07/2021 - 02/2010
15	Esophageal Squamous Cell Carcinoma 12/2022 - 06/2013
9	Inflammation (Inflammations) 01/2022 - 05/2015
9	Carcinoma (Carcinomatosis) 04/2021 - 01/2010
8	Lymphatic Metastasis 09/2020 - 06/2010
8	Neoplasm Metastasis (Metastasis) 01/2019 - 05/2009
6	Esophageal Neoplasms (Esophageal Cancer) 12/2020 - 01/2010
5	Colonic Neoplasms (Colon Cancer) 09/2020 - 06/2014
5	Carcinogenesis 01/2019 - 01/2015
5	Acute Lung Injury 01/2018 - 02/2013
4	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2018
4	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2020
4	Body Weight (Weight, Body) 03/2021 - 02/2013
4	Stomach Neoplasms (Stomach Cancer) 01/2020 - 11/2015
4	Obesity 06/2019 - 01/2017
4	Adenocarcinoma 06/2018 - 01/2014
4	Colorectal Neoplasms (Colorectal Cancer) 09/2014 - 01/2014
3	Lung Neoplasms (Lung Cancer) 01/2022 - 01/2021
3	Triple Negative Breast Neoplasms 01/2021 - 01/2018
3	Hemorrhage 11/2020 - 05/2015
3	Disease Progression 05/2014 - 03/2010
2	Autoimmune Diseases (Autoimmune Disease) 07/2022 - 10/2019
2	Glioma (Gliomas) 01/2022 - 01/2022
2	Dyslipidemias (Dyslipidemia) 11/2021 - 06/2020
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2020
2	Infections 11/2020 - 11/2009
2	Pneumonia (Pneumonitis) 11/2020 - 01/2020
2	Hepatocellular Carcinoma (Hepatoma) 10/2020 - 12/2010
2	Thrombosis (Thrombus) 01/2019 - 05/2015
2	Acute Cholecystitis 01/2019 - 01/2019
2	Asthma (Bronchial Asthma) 01/2018 - 08/2013
2	Acute-On-Chronic Liver Failure 05/2016 - 01/2015
2	Pathologic Complete Response 01/2015 - 09/2012
2	Lung Injury 01/2014 - 02/2013
2	Edema (Dropsy) 01/2014 - 02/2013
1	Heart Failure 09/2022

Drug/Important Bio-Agent (IBA)

12	Biomarkers (Surrogate Marker)IBA 01/2022 - 02/2013
12	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2013
7	Messenger RNA (mRNA)IBA 12/2021 - 04/2013
6	Phosphotransferases (Kinase)IBA 01/2022 - 01/2016
6	Pharmaceutical PreparationsIBA 01/2021 - 01/2014
5	MicroRNAs (MicroRNA)IBA 01/2022 - 06/2013
5	Estrogen ReceptorsIBA 02/2018 - 01/2015
4	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 08/2018
4	CytokinesIBA 12/2021 - 01/2015
4	LigandsIBA 10/2021 - 06/2010
4	LipopolysaccharidesIBA 10/2021 - 02/2013
4	Pyruvate KinaseIBA 05/2018 - 01/2015
4	DNA (Deoxyribonucleic Acid)IBA 01/2018 - 01/2010
3	6-chloropenicillanic acid S-sulfoxideIBA 12/2021 - 03/2020
3	CholesterolIBA 11/2021 - 01/2017
3	Indicators and Reagents (Reagents)IBA 04/2021 - 03/2010
3	ParaffinIBA 09/2020 - 01/2014
3	Coloring Agents (Dyes)IBA 01/2020 - 06/2016
3	CalciumIBA 11/2019 - 01/2018
3	Apolipoproteins E (ApoE)IBA 01/2019 - 05/2015
3	Progesterone Receptors (Progesterone Receptor)IBA 01/2018 - 01/2015
3	taxaneIBA 01/2016 - 01/2015
3	AntigensIBA 11/2015 - 12/2010
3	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2014 - 02/2013
2	Circular RNAIBA 01/2022 - 09/2019
2	Protein Kinases (Protein Kinase)IBA 01/2022 - 01/2018
2	IodineIBA 01/2022 - 01/2020
2	bisphenol AIBA 01/2022 - 03/2021
2	Eflornithine (Ornidyl)FDA Link 01/2022 - 01/2017
2	3,3'-diindolylmethane (diindolylmethane)IBA 01/2022 - 01/2019
2	Tyrosine Kinase InhibitorsIBA 12/2021 - 11/2020
2	Triglycerides (Triacylglycerol)IBA 11/2021 - 06/2020
2	HDL CholesterolIBA 11/2021 - 06/2020
2	LDL CholesterolIBA 11/2021 - 06/2020
2	Butylated Hydroxyanisole (BHA)IBA 11/2021 - 06/2020
2	oxidized low density lipoproteinIBA 11/2021 - 06/2020
2	IntegrinsIBA 10/2021 - 01/2018
2	Immunoglobulin E (IgE)IBA 10/2021 - 01/2018
2	Sialyl Lewis X AntigenIBA 04/2021 - 06/2010
2	Immunoglobulins (Immunoglobulin)IBA 01/2021 - 05/2016
2	ApolipoproteinsIBA 01/2019 - 05/2016
2	human ERBB2 proteinIBA 01/2018 - 01/2015
2	Cystatin CIBA 01/2018 - 01/2015
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 01/2017
2	CateninsIBA 11/2017 - 05/2017
2	IsoflavonesIBA 05/2017 - 03/2013
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2016 - 01/2015
2	Phenobarbital (Luminal)FDA Link 05/2015 - 11/2011
2	AnthracyclinesIBA 02/2015 - 01/2015
2	Sirtuin 1IBA 06/2014 - 01/2014
2	PhosgeneIBA 01/2014 - 02/2013
1	Fibrinogen (Factor I)FDA Link 09/2022
1	AlbuminsIBA 09/2022
1	Therapeutic UsesIBA 07/2022

Therapy/Procedure

10	Therapeutics 12/2022 - 12/2010
9	Drug Therapy (Chemotherapy) 01/2022 - 09/2012
5	Immunotherapy 11/2020 - 11/2011
4	Esophagectomy 12/2022 - 06/2021
4	Neoadjuvant Therapy 01/2021 - 09/2012
3	Radiotherapy 05/2021 - 01/2021
2	Gastrectomy 01/2020 - 06/2018
2	Cholecystostomy 01/2019 - 01/2019
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 09/2022